Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-11-051509
Filing Date
2011-09-07
Accepted
2011-09-07 11:58:57
Documents
1
Period of Report
2011-09-02

Document Format Files

Seq Description Document Type Size
1 form320746_20110907115858-.html 3  
1 form320746_20110907115858-.xml 3 1453
  Complete submission text file 0001144204-11-051509.txt   2746
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Issuer) CIK: 0000811641 (see all company filings)

EIN.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address
Cunningham David (Reporting) CIK: 0001529247 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-12934 | Film No.: 111077497